Edition:
India

Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

22.37USD
24 Jun 2016
Change (% chg)

$-0.60 (-2.61%)
Prev Close
$22.97
Open
$22.35
Day's High
$22.95
Day's Low
$22.34
Volume
16,765,869
Avg. Vol
2,837,282
52-wk High
$23.35
52-wk Low
$14.18

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven core businesses: Interventional Cardiology, Peripheral Interventions (PI), Cardiac Rhythm Management (CRM), Electrophysiology (EP),... (more)

Overall

Beta: 0.98
Market Cap(Mil.): $31,167.23
Shares Outstanding(Mil.): 1,356.87
Dividend: --
Yield (%): --

Financials

Exclusive: Bayer explores sale of radiology business - sources

NEW YORK/FRANKFURT Bayer AG, the German chemicals and healthcare company trying to acquire Monsanto Co, is exploring a sale of its radiology supplies unit that could be worth more than $3 billion, according to people familiar with the matter.

18 Jun 2016

Exclusive: Bayer explores sale of radiology business - sources

NEW YORK/FRANKFURT Bayer AG , the German chemicals and healthcare company trying to acquire Monsanto Co , is exploring a sale of its radiology supplies unit that could be worth more than $3 billion, according to people familiar with the matter.

17 Jun 2016

BRIEF-Boston Scientific reaffirms 2016 revenue guidance

* Reaffirms FY 2016 revenue guidance provided on April 27, for estimated revenue to be in a range of $8.075 to $8.225 billion

09 Jun 2016

Boston Scientific to restructure in bid to reduce operating expenses

Medical device maker Boston Scientific Corp said on Wednesday it would undergo a global restructuring program that is expected to save the company up to $150 million by 2020.

09 Jun 2016

Boston Scientific to restructure in bid to reduce operating expenses

June 8 Medical device maker Boston Scientific Corp said on Wednesday it would undergo a global restructuring program that is expected to save the company up to $150 million by 2020.

09 Jun 2016

BRIEF-Boston Scientific announces positive long-term outcomes for S-ICD system

* Boston scientific announces positive long-term outcomes for S-ICD system in the EFFORTLESS study

07 May 2016

BRIEF-Boston Scientific announces FDA approval of navigation-enabled ablation catheters

* Announces U.S. FDA approval of navigation-enabled ablation catheters Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

04 May 2016

UPDATE 3-Boston Scientific profit beats as heart stent sales rise

April 27 Boston Scientific Corp reported a better-than-expected quarterly profit, boosted by higher sales of its heart stents and clot-removal product, and the medical device maker raised its full-year revenue forecast.

27 Apr 2016

BRIEF-Boston Scientific Q1 adjusted EPS $0.28 excluding items

* Q1 earnings per share view $0.24 -- Thomson Reuters I/B/E/S

27 Apr 2016

BRIEF-Boston Scientific receives U.S. FDA approval for ImageReady MR-conditional pacing system

* Receives U.S. FDA approval for Imageready(Tm) MR-conditional pacing system

26 Apr 2016

Competitors

  Price Chg
Abbott Laboratories (ABT.N) $37.91 -1.72
St. Jude Medical, Inc. (STJ.N) $76.88 -1.61
Medtronic PLC (MDT.N) $83.26 -2.51

Earnings vs. Estimates